Sec. 221. LIMITATION ON AVAILABILITY OF FUNDS FOR THE ADVANCED DEVELOPMENT AND MANUFACTURING FACILITY UNDER THE MEDICAL COUNTERMEASURE PROGRAM
355 words·~2 min read·
/statute-compilations/comps-11831/sec-221A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 221 LIMITATION ON AVAILABILITY OF FUNDS FOR THE ADVANCED DEVELOPMENT AND MANUFACTURING FACILITY UNDER THE MEDICAL COUNTERMEASURE PROGRAM ###
(a)Limitation Of the funds authorized to be appropriated by this Act or otherwise made available for fiscal year 2016 for research, development, test, and evaluation, Defense-wide, for the advanced development and manufacturing facility, and the associated activities performed at such facility, under the medical countermeasure program of the chemical and biological defense program, not more than 75 percent may be obligated or expended until a period of 45 days elapses following the date on which the Secretary of Defense submits to the congressional defense committees the report under subsection (b). ###
(b)Report The Secretary shall submit to the congressional defense committees a report on the advanced development and manufacturing facility under the medical countermeasure program that includes the following: ####
(1)An overall description of the advanced development and manufacturing facility, including validated Department of Defense requirements. ####
(2)Program goals, proposed metrics of performance, and anticipated procurement and operations and maintenance costs during the period covered by the current future years defense program under section 221 of title 10, United States Code. ####
(3)The results of any analysis of alternatives and efficiency reviews conducted by the Secretary that justifies the manufacturing and privately financed construction of an advanced manufacturing and development facility rather than using other programs and facilities of the Federal Government or industry facilities for advanced development and manufacturing of medical countermeasures. ####
(4)An independent cost-benefit analysis that justifies the manufacturing and privately financed construction of an advanced manufacturing and development facility described in paragraph (3). ####
(5)If no independent cost-benefit analysis makes the justification described in paragraph (4), an explanation for why such manufacturing and privately financed construction cannot be so justified. ####
(6)Any other matters the Secretary of Defense determines appropriate. ###
(c)Comptroller General Review Not later than 60 days after the date on which the Secretary submits the report under subsection (b), the Comptroller General of the United States shall submit to the congressional defense committees a review of such report.